{"output": [["Kala Pharmaceuticals Inc.", "COMP", "Has", "KPI-121", "PRODUCT"], ["Kala Pharmaceuticals Inc.", "COMP", "Operate_In", "Pharmaceutical Industry", "SECTOR"], ["KPI-121", "PRODUCT", "Relate_To", "Dry Eye Disease", "CONCEPT"], ["KPI-121", "PRODUCT", "Participates_In", "Late-Stage Studies", "EVENT"], ["Kala Pharmaceuticals Inc.", "COMP", "Control", "Shares", "FIN_INSTRUMENT"], ["Shares", "FIN_INSTRUMENT", "Decrease", "16", "ECON_INDICATOR"], ["Kala Pharmaceuticals Inc.", "COMP", "Has", "First Trial", "EVENT"], ["First Trial", "EVENT", "Positive_Impact_On", "Dry Eye Treatment", "CONCEPT"], ["Kala Pharmaceuticals Inc.", "COMP", "Has", "U.S. Regulator", "ORG/REG"], ["U.S. Regulator", "ORG/REG", "Relate_To", "FDA", "ORG/GOV"], ["Kala Pharmaceuticals Inc.", "COMP", "Has", "Path Forward", "CONCEPT"], ["Kala Pharmaceuticals Inc.", "COMP", "Has", "Post-Marketing Trial", "EVENT"], ["KPI-121", "PRODUCT", "Potential", "Peak Sales", "ECON_INDICATOR"], ["Kala Pharmaceuticals Inc.", "COMP", "Has", "Inveltys", "PRODUCT"], ["Inveltys", "PRODUCT", "Under_Review", "FDA", "ORG/GOV"], ["FDA", "ORG/GOV", "Expected", "Decision", "EVENT"]], "published": "2018-01-05T14:53:00.000+02:00"}